Avaliação de resposta e sobrevida dos pacientes portadores de linfoma de células do manto submetidos ao transplante autólogo de células tronco hematopoiéticas
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Background: Mantle cell lymphoma (MCL) is a rare and aggressive non-Hodgkin lymphoma
subtype characterized by the t(11;14) (q13;q32) translocation, leading to cyclin D1
overexpression and cell cycle dysregulation. Despite advances in therapy, MCL remains
incurable, typically displaying relapsing disease requiring successive treatment lines, posing
significant challenges, especially in elderly patients. Methods: This retrospective, multicenter
study evaluated the clinical, laboratory, and prognostic profiles of 40 patients with confirmed
MCL who underwent autologous stem cell transplantation (ASCT) as consolidation therapy
between 2004 and 2024 at two oncology centers in Minas Gerais, Brazil. Additional data from
the Brazilian Mantle Cell Lymphoma Registry were incorporated. The study also investigated
the impact of cytarabine use in the conditioning regimen on overall survival (OS) and
progression-free survival (PFS). Results: Patients receiving cytarabine demonstrated
significantly improved 3-year OS and PFS compared to those who did not (64% vs. 27% for
PFS, p<0.01). Multivariate Cox regression analysis identified cytarabine use as a significant
protective factor, reducing the risk of death by 89% (HR=0.11; 95% CI: 0.017–0.71; p=0.021)
and the risk of progression by 84% (HR = 0.16; 95% CI: 0.02–0.93; p = 0.04). Although the
Mantle Cell Lymphoma International Prognostic Index (MIPI) did not show a statistically
significant association with survival, a trend toward better outcomes in low/intermediate-risk
groups was observed. Conclusions: This study reinforces the therapeutic potential of
cytarabine in conditioning regimens for MCL patients undergoing ASCT, aligning with
international literature.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

